Clariane

Reiterated outlook backed by a buoyant Q1

26/04/24 -"Clariane reported 7.4% growth in its Q1 statutory and organic revenue, with the dynamism being witnessed in all the segments and regions. The financial objectives were maintained. Regarding the ..."

PDF page sample
Pages
60
Language
English
Published on
26/04/24
Download
You may also be interested by these reports :
07/05/24
CEO Helen Giza clarified that the implementation of the operating model, once announced, would be a marathon, not a sprint. She acknowledged ...
07/05/24
Amplifon’s Q1 results were in line with the company-compiled consensus. The mid-single-digit top-line growth was supported by the contributions from ...
07/05/24
The management expressed confidence in a stronger second half to the year, as Imaging’s revenue and profitability are set to improve sequentially ...
06/05/24
Demant’s Q1 sales missed the company-compiled consensus. The low-single-digit growth was led by positive contributions from Hearing Aids and ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO